The classical linear progression model implies that a CRA is initiated by two genetic alterations at the level of the APC gene and progresses to invasive CRC through a progressive, stepwise acquisition of additional genetic alterations involving driver gene mutations such as KRAS and TP53 and deletion of chromosome 18q4 [74]. The gene discussed is TP53; the disease is colorectal carcinoma.